Cortical and subcortical neuroanatomical signatures of schizotypy in 3004 individuals assessed in a worldwide ENIGMA study.


Journal

Molecular psychiatry
ISSN: 1476-5578
Titre abrégé: Mol Psychiatry
Pays: England
ID NLM: 9607835

Informations de publication

Date de publication:
02 2022
Historique:
received: 15 04 2021
accepted: 08 10 2021
revised: 02 10 2021
pubmed: 29 10 2021
medline: 4 5 2022
entrez: 28 10 2021
Statut: ppublish

Résumé

Neuroanatomical abnormalities have been reported along a continuum from at-risk stages, including high schizotypy, to early and chronic psychosis. However, a comprehensive neuroanatomical mapping of schizotypy remains to be established. The authors conducted the first large-scale meta-analyses of cortical and subcortical morphometric patterns of schizotypy in healthy individuals, and compared these patterns with neuroanatomical abnormalities observed in major psychiatric disorders. The sample comprised 3004 unmedicated healthy individuals (12-68 years, 46.5% male) from 29 cohorts of the worldwide ENIGMA Schizotypy working group. Cortical and subcortical effect size maps with schizotypy scores were generated using standardized methods. Pattern similarities were assessed between the schizotypy-related cortical and subcortical maps and effect size maps from comparisons of schizophrenia (SZ), bipolar disorder (BD) and major depression (MDD) patients with controls. Thicker right medial orbitofrontal/ventromedial prefrontal cortex (mOFC/vmPFC) was associated with higher schizotypy scores (r = 0.067, p

Identifiants

pubmed: 34707236
doi: 10.1038/s41380-021-01359-9
pii: 10.1038/s41380-021-01359-9
pmc: PMC9054674
mid: EMS136389
doi:

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1167-1176

Subventions

Organisme : Wellcome Trust
ID : 202397/Z/16/Z
Pays : United Kingdom
Organisme : NIBIB NIH HHS
ID : U54 EB020403
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom

Informations de copyright

© 2021. The Author(s).

Références

Debbané M, Eliez S, Badoud D, Conus P, Flückiger R, Schultze-Lutter F. Developing psychosis and its risk states through the lens of schizotypy. Schizophr Bull. 2015;41:S396–407.
pubmed: 25548386 doi: 10.1093/schbul/sbu176
Everett KV, Linscott RJ. Dimensionality vs taxonicity of schizotypy: some new data and challenges ahead. Schizophr Bull 2015;41:S465–474.
pubmed: 25810059 pmcid: 4373639 doi: 10.1093/schbul/sbu221
van Os J, Linscott RJ, Myin-Germeys I, Delespaul P, Krabbendam L. A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychol Med. 2009;39:179–95.
pubmed: 18606047 doi: 10.1017/S0033291708003814
Lenzenweger MF. Schizotaxia, schizotypy, and schizophrenia: Paul E. Meehl’s blueprint for the experimental psychopathology and genetics of schizophrenia. J Abnorm Psychol. 2006;115:195–200.
pubmed: 16737381 doi: 10.1037/0021-843X.115.2.195
Meehl PE. Schizotaxia, schizotypy, schizophrenia. Am Psychol. 1962;17:827–38.
doi: 10.1037/h0041029
Rado S. Dynamics and classification of disordered behavior. Am J Psychiatry. 1953;110:406–16.
pubmed: 13104683 doi: 10.1176/ajp.110.6.406
Grant P, Green MJ, Mason OJ. Models of schizotypy: the importance of conceptual clarity. Schizophr Bull. 2018;44:S556–S563.
pubmed: 29474661 pmcid: 6188508 doi: 10.1093/schbul/sby012
Claridge G. Schizotypy: implications for illness and health. New York, NY, US: Oxford University Press; 1997.
Kwapil TR, Barrantes-Vidal N. Schizotypy: looking back and moving forward. Schizophr Bull. 2015;41:S366–S373.
pubmed: 25548387 doi: 10.1093/schbul/sbu186
Vollema MG, van den Bosch RJ. The multidimensionality of schizotypy. Schizophr Bull. 1995;21:19–31.
pubmed: 7770738 doi: 10.1093/schbul/21.1.19
Oezgen M, Grant P. Odd and disorganized–Comparing the factor structure of the three major schizotypy inventories. Psychiatry Res. 2018;267:289–95.
pubmed: 29945071 doi: 10.1016/j.psychres.2018.06.009
Cicero DC, Jonas KG, Li K, Perlman G, Kotov R. Common taxonomy of traits and symptoms: linking schizophrenia symptoms, schizotypy, and normal personality. Schizophr Bull. 2019;45:1336–48.
pubmed: 30753725 pmcid: 6811822 doi: 10.1093/schbul/sbz005
Schultze-Lutter F, Nenadic I, Grant P. Psychosis and Schizophrenia-Spectrum Personality Disorders Require Early Detection on Different Symptom Dimensions. Front Psychiatry. 2019;10:476.
doi: 10.3389/fpsyt.2019.00476 pubmed: 31354543 pmcid: 6637034
Kemp KC, Bathery AJ, Barrantes-Vidal N, Kwapil TR. Positive, Negative, and Disorganized Schizotypy Predict Differential Patterns of Interview-Rated Schizophrenia-Spectrum Symptoms and Impairment: Assessment. 2020. 19 January 2020. https://doi.org/10.1177/1073191119900008 .
Flückiger R, Ruhrmann S, Debbané M, Michel C, Hubl D, Schimmelmann BG, et al. Psychosis-predictive value of self-reported schizotypy in a clinical high-risk sample. J Abnorm Psychol. 2016;125:923–32.
pubmed: 27583768 doi: 10.1037/abn0000192
Barrantes-Vidal N, Grant P, Kwapil TR. The role of schizotypy in the study of the etiology of schizophrenia spectrum disorders. Schizophr Bull. 2015;41:S408–416.
pubmed: 25810055 pmcid: 4373635 doi: 10.1093/schbul/sbu191
Kirschner M, Haugg A, Manoliu A, Simon JJ, Huys QJM, Seifritz E, et al. Deficits in context-dependent adaptive coding in early psychosis and healthy individuals with schizotypal personality traits. Brain J Neurol. 2018;141:2806–19.
doi: 10.1093/brain/awy203
Kirschner M, Hager OM, Muff L, Bischof M, Hartmann-Riemer MN, Kluge A, et al. Ventral Striatal Dysfunction and Symptom Expression in Individuals With Schizotypal Personality Traits and Early Psychosis. Schizophr Bull. 2018;44:147–57.
pubmed: 27798223 doi: 10.1093/schbul/sby015.204
Modinos G, Egerton A, McLaughlin A, McMullen K, Kumari V, Lythgoe DJ, et al. Neuroanatomical changes in people with high schizotypy: relationship to glutamate levels. Psychol Med. 2018;48:1880–89.
pubmed: 29198207 doi: 10.1017/S0033291717003403
Nelson MT, Seal ML, Pantelis C, Phillips LJ. Evidence of a dimensional relationship between schizotypy and schizophrenia: a systematic review. Neurosci Biobehav Rev. 2013;37:317–27.
pubmed: 23313650 doi: 10.1016/j.neubiorev.2013.01.004
Ronald A, Pain O. A systematic review of genome-wide research on psychotic experiences and negative symptom traits: new revelations and implications for psychiatry. Hum Mol Genet. 2018;27:R136–R152.
pubmed: 29741616 pmcid: 6061705
Sabaroedin K, Tiego J, Parkes L, Sforazzini F, Finlay A, Johnson B, et al. Functional Connectivity of Corticostriatal Circuitry and Psychosis-like Experiences in the General Community. Biol Psychiatry. 2019;86:16–24.
pubmed: 30952359 doi: 10.1016/j.biopsych.2019.02.013
Sahakyan L, Meller T, Evermann U, Schmitt S, Pfarr J-K, Sommer J, et al. Anterior vs Posterior Hippocampal Subfields in an Extended Psychosis Phenotype of Multidimensional Schizotypy in a Nonclinical Sample. Schizophr Bull. 2020;21:2020 https://doi.org/10.1093/schbul/sbaa099 . July.
doi: 10.1093/schbul/sbaa099
Rapoport JL, Giedd JN, Gogtay N. Neurodevelopmental model of schizophrenia: update 2012. Mol Psychiatry 2012;17:1228–38.
pubmed: 22488257 pmcid: 3504171 doi: 10.1038/mp.2012.23
Insel TR. Rethinking schizophrenia. Nature. 2010;468:187–93.
pubmed: 21068826 doi: 10.1038/nature09552
Debbané M, Barrantes-Vidal N. Schizotypy from a developmental perspective. Schizophr Bull 2015;41:S386–395.
pubmed: 25548385 doi: 10.1093/schbul/sbu175
Wannan CMJ, Cropley VL, Chakravarty MM, Bousman C, Ganella EP, Bruggemann JM, et al. Evidence for Network-Based Cortical Thickness Reductions in Schizophrenia. Am J Psychiatry. 2019;176:552–63.
pubmed: 31164006 doi: 10.1176/appi.ajp.2019.18040380
van Erp TGM, Walton E, Hibar DP, Schmaal L, Jiang W, Glahn DC, et al. Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium. Biol Psychiatry. 2018;84:644–54.
pubmed: 29960671 pmcid: 6177304 doi: 10.1016/j.biopsych.2018.04.023
Vieira S, Gong Q, Scarpazza C, Lui S, Huang X, Crespo-Facorro B, et al. Neuroanatomical abnormalities in first-episode psychosis across independent samples: a multi-centre mega-analysis. Psychol Med. 2021;51:340–50.
doi: 10.1017/S0033291719003568 pubmed: 31858920
Fusar-Poli P, Borgwardt S, Crescini A, Deste G, Kempton MJ, Lawrie S, et al. Neuroanatomy of vulnerability to psychosis: a voxel-based meta-analysis. Neurosci Biobehav Rev. 2011;35:1175–85.
pubmed: 21168439 doi: 10.1016/j.neubiorev.2010.12.005
Koutsouleris N, Schmitt GJE, Gaser C, Bottlender R, Scheuerecker J, McGuire P, et al. Neuroanatomical correlates of different vulnerability states for psychosis and their clinical outcomes. Br J Psychiatry J Ment Sci. 2009;195:218–26.
doi: 10.1192/bjp.bp.108.052068
Fervaha G, Remington G. Neuroimaging findings in schizotypal personality disorder: a systematic review. Prog Neuropsychopharmacol Biol Psychiatry. 2013;43:96–107.
pubmed: 23220094 doi: 10.1016/j.pnpbp.2012.11.014
van Lutterveld R, van den Heuvel MP, Diederen KMJ, de Weijer AD, Begemann MJH, Brouwer RM, et al. Cortical thickness in individuals with non-clinical and clinical psychotic symptoms. Brain. 2014;137:2664–9.
pubmed: 24951640 doi: 10.1093/brain/awu167
van Erp TGM, Hibar DP, Rasmussen JM, Glahn DC, Pearlson GD, Andreassen OA, et al. Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Mol Psychiatry. 2016;21:547–53.
pubmed: 26033243 doi: 10.1038/mp.2015.63
Derome M, Tonini E, Zöller D, Schaer M, Eliez S, Debbané M. Developmental Trajectories of Cortical Thickness in Relation to Schizotypy During Adolescence. Schizophr Bull. 2020;5:2020 https://doi.org/10.1093/schbul/sbaa020 . March.
doi: 10.1093/schbul/sbaa020
DeRosse P, Nitzburg GC, Ikuta T, Peters BD, Malhotra AK, Szeszko PR. Evidence from structural and diffusion tensor imaging for frontotemporal deficits in psychometric schizotypy. Schizophr Bull. 2015;41:104–14.
pubmed: 25392520 doi: 10.1093/schbul/sbu150
Ettinger U, Williams SCR, Meisenzahl EM, Möller H-J, Kumari V, Koutsouleris N. Association between brain structure and psychometric schizotypy in healthy individuals. World J Biol Psychiatry Off J World Fed Soc. Biol Psychiatry. 2012;13:544–9.
Kühn S, Gallinat J. Quantitative meta-analysis on state and trait aspects of auditory verbal hallucinations in schizophrenia. Schizophr Bull. 2012;38:779–86.
pubmed: 21177743 doi: 10.1093/schbul/sbq152
Meller T, Schmitt S, Ettinger U, Grant P, Stein F, Brosch K, et al. Brain structural correlates of schizotypal signs and subclinical schizophrenia nuclear symptoms in healthy individuals. Psychol Med. 2020:1-10. https://doi.org/10.1017/S0033291720002044 . Epub ahead of print.
Modinos G, Mechelli A, Ormel J, Groenewold NA, Aleman A, McGuire PK. Schizotypy and brain structure: a voxel-based morphometry study. Psychol Med. 2010;40:1423–31.
pubmed: 19917146 doi: 10.1017/S0033291709991875
Nenadic I, Lorenz C, Langbein K, Dietzek M, Smesny S, Schönfeld N, et al. Brain structural correlates of schizotypy and psychosis proneness in a non-clinical healthy volunteer sample. Schizophr Res. 2015;168:37–43.
pubmed: 26164819 doi: 10.1016/j.schres.2015.06.017
Wiebels K, Waldie KE, Roberts RP, Park HRP. Identifying grey matter changes in schizotypy using partial least squares correlation. Cortex J Devoted Study Nerv Syst Behav. 2016;81:137–50.
doi: 10.1016/j.cortex.2016.04.011
Kirschner M, Schmidt A, Hodzic-Santor B, Burrer A, Manoliu A, Zeighami Y, et al. Orbitofrontal-Striatal Structural Alterations Linked to Negative Symptoms at Different Stages of the Schizophrenia Spectrum. Schizophr Bull. 2020;1:2020 https://doi.org/10.1093/schbul/sbaa169 . December.
doi: 10.1093/schbul/sbaa169
Modinos G, Egerton A, McLaughlin A, McMullen K, Kumari V, Lythgoe DJ, et al. Neuroanatomical changes in people with high schizotypy: relationship to glutamate levels. Psychol Med. 2018;48:1880–9.
pubmed: 29198207 doi: 10.1017/S0033291717003403
Wang Y, Yan C, Yin D, Fan M, Cheung EFC, Pantelis C, et al. Neurobiological Changes of Schizotypy: Evidence From Both Volume-Based Morphometric Analysis and Resting-State Functional Connectivity. Schizophr Bull. 2015;41:S444–S454.
pubmed: 25533270 doi: 10.1093/schbul/sbu178
Pfarr J-K, Nenadić I. A multimodal imaging study of brain structural correlates of schizotypy dimensions using the MSS. Psychiatry Res Neuroimaging. 2020;302:111104.
pubmed: 32474373 doi: 10.1016/j.pscychresns.2020.111104
Walton E, Hibar DP, van Erp TGM, Potkin SG, Roiz-Santiañez R, Crespo-Facorro B, et al. Prefrontal cortical thinning links to negative symptoms in schizophrenia via the ENIGMA consortium. Psychol Med. 2018;48:82–94.
pubmed: 28545597 doi: 10.1017/S0033291717001283
Walton E, Hibar DP, van Erp TG, Potkin SG, Roiz-Santiañez R, Crespo-Facorro B, et al. Positive symptoms associate with cortical thinning in the superior temporal gyrus via the ENIGMA-Schizophrenia consortium. Acta Psychiatr Scand. 2017;135:439–47.
pubmed: 28369804 pmcid: 5399182 doi: 10.1111/acps.12718
Chapman LJ, Chapman JP, Raulin ML. Body-image aberration in schizophrenia. J Abnorm Psychol. 1978;87:399–407.
pubmed: 681612 doi: 10.1037/0021-843X.87.4.399
Chapman LJ, Chapman JP, Raulin ML. Scales for physical and social anhedonia. J Abnorm Psychol. 1976;85:374–82.
pubmed: 956504 doi: 10.1037/0021-843X.85.4.374
Eckblad M, Chapman LJ. Magical ideation as an indicator of schizotypy. J Consult Clin Psychol. 1983;51:215–25.
pubmed: 6841765 doi: 10.1037/0022-006X.51.2.215
Stefanis NC, Hanssen M, Smirnis NK, Avramopoulos DA, Evdokimidis IK, Stefanis CN, et al. Evidence that three dimensions of psychosis have a distribution in the general population. Psychol Med. 2002;32:347–58.
pubmed: 11866327 doi: 10.1017/S0033291701005141
Raine A. The SPQ: a scale for the assessment of schizotypal personality based on DSM-III-R criteria. Schizophr Bull. 1991;17:555–64.
pubmed: 1805349 doi: 10.1093/schbul/17.4.555
Mason O, Claridge G, Jackson M. New scales for the assessment of schizotypy. Personal Individ Differ. 1995;18:7–13.
doi: 10.1016/0191-8869(94)00132-C
Rust J. The Rust Inventory of Schizoid Cognitions (RISC): a psychometric measure of psychoticism in the normal population. Br J Clin Psychol. 1987;26:151–2.
pubmed: 3580653 doi: 10.1111/j.2044-8260.1987.tb00744.x
Kirschner M, Hodzic-Santor B, Kircher T, Nenadic I, Fornito A, Green M, et al. T162. Thicker prefrontal cortex is associated with subclinical negative symptoms in schizotypy - an enigma consortium meta-analysis. Schizophr Bull. 2020;46:S292–S293.
pmcid: 7234734 doi: 10.1093/schbul/sbaa029.722
Fischl B. FreeSurfer. NeuroImage 2012;62:774–81.
pubmed: 22248573 doi: 10.1016/j.neuroimage.2012.01.021
Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, et al. Whole Brain Segmentation: Automated Labeling of Neuroanatomical Structures in the Human Brain. Neuron. 2002;33:341–55.
pubmed: 11832223 doi: 10.1016/S0896-6273(02)00569-X
Desikan RS, Ségonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. NeuroImage. 2006;31:968–80.
pubmed: 16530430 doi: 10.1016/j.neuroimage.2006.01.021
Hanlon CA, Owens MM, Joseph JE, Zhu X, George MS, Brady KT, et al. Lower subcortical gray matter volume in both younger smokers and established smokers relative to non-smokers. Addict Biol. 2016;21:185–95.
pubmed: 25125263 doi: 10.1111/adb.12171
Karama S, Ducharme S, Corley J, Chouinard-Decorte F, Starr JM, Wardlaw JM, et al. Cigarette smoking and thinning of the brain’s cortex. Mol Psychiatry. 2015;20:778–85.
pubmed: 25666755 pmcid: 4430302 doi: 10.1038/mp.2014.187
Viechtbauer W. Conducting Meta-Analyses in R with the metafor Package. J Stat Softw. 2010;36:1–48.
doi: 10.18637/jss.v036.i03
Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol. 1995;57:289–300.
Storey JD. A Direct Approach to False Discovery Rates. J R Stat Soc Ser B Stat Methodol. 2002;64:479–98.
doi: 10.1111/1467-9868.00346
Hibar DP, Westlye LT, Doan NT, Jahanshad N, Cheung JW, Ching CRK, et al. Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group. Mol Psychiatry. 2018;23:932–42.
pubmed: 28461699 doi: 10.1038/mp.2017.73
Hibar DP, Westlye LT, van Erp TGM, Rasmussen J, Leonardo CD, Faskowitz J, et al. Subcortical volumetric abnormalities in bipolar disorder. Mol Psychiatry. 2016;21:1710–16.
pubmed: 26857596 pmcid: 5116479 doi: 10.1038/mp.2015.227
Schmaal L, Hibar DP, Sämann PG, Hall GB, Baune BT, Jahanshad N, et al. Cortical abnormalities in adults and adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA Major Depressive Disorder Working Group. Mol Psychiatry. 2017;22:900–9.
pubmed: 27137745 doi: 10.1038/mp.2016.60
Schmaal L, Veltman DJ, van Erp TGM, Sämann PG, Frodl T, Jahanshad N, et al. Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working group. Mol Psychiatry. 2016;21:806–12.
pubmed: 26122586 doi: 10.1038/mp.2015.69
Sun D, Ching CRK, Lin A, Forsyth JK, Kushan L, Vajdi A, et al. Large-scale mapping of cortical alterations in 22q11.2 deletion syndrome: Convergence with idiopathic psychosis and effects of deletion size. Mol Psychiatry. 2020;25:1822–34. https://doi.org/10.1038/s41380-018-0078-5 .
doi: 10.1038/s41380-018-0078-5 pubmed: 29895892
Opel N, Goltermann J, Hermesdorf M, Berger K, Baune BT, Dannlowski U. Cross-Disorder Analysis of Brain Structural Abnormalities in Six Major Psychiatric Disorders: A Secondary Analysis of Mega- and Meta-analytical Findings From the ENIGMA Consortium. Biol Psychiatry. 2020;88:678–86. https://doi.org/10.1016/j.biopsych.2020.04.027 .
doi: 10.1016/j.biopsych.2020.04.027 pubmed: 32646651
Larivière S, Rodríguez-Cruces R, Royer J, Caligiuri ME, Gambardella A, Concha L, et al. Network-based atrophy modeling in the common epilepsies: a worldwide ENIGMA study. Sci Adv. 2020;6:eabc6457.
pubmed: 33208365 pmcid: 7673818 doi: 10.1126/sciadv.abc6457
Alexander-Bloch AF, Shou H, Liu S, Satterthwaite TD, Glahn DC, Shinohara RT, et al. On testing for spatial correspondence between maps of human brain structure and function. NeuroImage. 2018;178:540–51.
pubmed: 29860082 doi: 10.1016/j.neuroimage.2018.05.070
Markello RD, Misic B. Comparing spatial null models for brain maps. NeuroImage. 2021;236:118052.
pubmed: 33857618 doi: 10.1016/j.neuroimage.2021.118052
de Winter JCF, Gosling SD, Potter J. Comparing the Pearson and Spearman correlation coefficients across distributions and sample sizes: A tutorial using simulations and empirical data. Psychol Methods. 2016;21:273–90.
pubmed: 27213982 doi: 10.1037/met0000079
Diedenhofen B, Musch J. cocor: a Comprehensive Solution for the Statistical Comparison of Correlations. PLOS ONE. 2015;10:e0121945.
pubmed: 25835001 pmcid: 4383486 doi: 10.1371/journal.pone.0121945
Ren W, Lui S, Deng W, Li F, Li M, Huang X, et al. Anatomical and functional brain abnormalities in drug-naive first-episode schizophrenia. Am J Psychiatry. 2013;170:1308–16.
pubmed: 23732942 doi: 10.1176/appi.ajp.2013.12091148
Xiao Y, Lui S, Deng W, Yao L, Zhang W, Li S, et al. Altered Cortical Thickness Related to Clinical Severity But Not the Untreated Disease Duration in Schizophrenia. Schizophr Bull. 2015;41:201–10.
pubmed: 24353097 doi: 10.1093/schbul/sbt177
Dukart J, Smieskova R, Harrisberger F, Lenz C, Schmidt A, Walter A, et al. Age-related brain structural alterations as an intermediate phenotype of psychosis. J Psychiatry Neurosci JPN. 2017;42:307–19.
pubmed: 28459416 doi: 10.1503/jpn.160179
Li X, Alapati V, Jackson C, Xia S, Bertisch HC, Branch CA, et al. Structural abnormalities in language circuits in genetic high-risk subjects and schizophrenia patients. Psychiatry Res Neuroimaging. 2012;201:182–9.
doi: 10.1016/j.pscychresns.2011.07.017
Klauser P, Zhou J, Lim JKW, Poh JS, Zheng H, Tng HY, et al. Lack of Evidence for Regional Brain Volume or Cortical Thickness Abnormalities in Youths at Clinical High Risk for Psychosis: Findings From the Longitudinal Youth at Risk Study. Schizophr Bull. 2015;41:1285–93.
pubmed: 25745033 pmcid: 4601700 doi: 10.1093/schbul/sbv012
Jung WH, Kim JS, Jang JH, Choi J-S, Jung MH, Park J-Y, et al. Cortical thickness reduction in individuals at ultra-high-risk for psychosis. Schizophr Bull. 2011;37:839–49.
pubmed: 20026559 doi: 10.1093/schbul/sbp151
Chung Y, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, et al. Use of Machine Learning to Determine Deviance in Neuroanatomical Maturity Associated With Future Psychosis in Youths at Clinically High Risk. JAMA Psychiatry. 2018;75:960–8.
pubmed: 29971330 pmcid: 6142910 doi: 10.1001/jamapsychiatry.2018.1543
Buechler R, Wotruba D, Michels L, Theodoridou A, Metzler S, Walitza S, et al. Cortical Volume Differences in Subjects at Risk for Psychosis Are Driven by Surface Area. Schizophr Bull. 2020;28:2020 https://doi.org/10.1093/schbul/sbaa066 . May.
doi: 10.1093/schbul/sbaa066
Cannon TD, Chung Y, He G, Sun D, Jacobson A, van Erp TGM, et al. Progressive Reduction in Cortical Thickness as Psychosis Develops: A Multisite Longitudinal Neuroimaging Study of Youth at Elevated Clinical Risk. Biol Psychiatry. 2015;77:147–57.
pubmed: 25034946 doi: 10.1016/j.biopsych.2014.05.023
Borgwardt SJ, McGuire PK, Aston J, Gschwandtner U, Pflüger MO, Stieglitz R-D, et al. Reductions in frontal, temporal and parietal volume associated with the onset of psychosis. Schizophr Res. 2008;106:108–14.
pubmed: 18789654 doi: 10.1016/j.schres.2008.08.007
Koutsouleris N, Kambeitz-Ilankovic L, Ruhrmann S, Rosen M, Ruef A, Dwyer DB, et al. Prediction Models of Functional Outcomes for Individuals in the Clinical High-Risk State for Psychosis or With Recent-Onset Depression: A Multimodal, Multisite Machine Learning Analysis. JAMA Psychiatry. 2018;75:1156–72.
pubmed: 30267047 pmcid: 6248111 doi: 10.1001/jamapsychiatry.2018.2165
Sun D, Phillips L, Velakoulis D, Yung A, McGorry PD, Wood SJ, et al. Progressive brain structural changes mapped as psychosis develops in ‘at risk’ individuals. Schizophr Res. 2009;108:85–92.
pubmed: 19138834 pmcid: 2670732 doi: 10.1016/j.schres.2008.11.026
Takahashi T, Wood SJ, Yung AR, Phillips LJ, Soulsby B, McGorry PD, et al. Insular cortex gray matter changes in individuals at ultra-high-risk of developing psychosis. Schizophr Res. 2009;111:94–102.
pubmed: 19349150 doi: 10.1016/j.schres.2009.03.024
van Rooij D, Anagnostou E, Arango C, Auzias G, Behrmann M, Busatto GF, et al. Cortical and Subcortical Brain Morphometry Differences Between Patients With Autism Spectrum Disorder and Healthy Individuals Across the Lifespan: Results From the ENIGMA ASD Working Group. Am J Psychiatry. 2018;175:359–69.
pubmed: 29145754 doi: 10.1176/appi.ajp.2017.17010100
Gong J-B, Wang Y, Lui SSY, Cheung EFC, Chan RCK. Childhood trauma is not a confounder of the overlap between autistic and schizotypal traits: A study in a non-clinical adult sample. Psychiatry Res. 2017;257:111–7.
pubmed: 28750214 doi: 10.1016/j.psychres.2017.07.035
Zhou H-Y, Yang H-X, Gong J-B, Cheung EFC, Gooding DC, Park S, et al. Revisiting the overlap between autistic and schizotypal traits in the non-clinical population using meta-analysis and network analysis. Schizophr Res. 2019;212:6–14.
pubmed: 31387828 doi: 10.1016/j.schres.2019.07.050
Fonseca-Pedrero E, Debbané M, Schneider M, Badoud D, Eliez S. Schizotypal traits in adolescents with 22q11.2 deletion syndrome: validity, reliability and risk for psychosis. Psychol Med. 2016;46:1005–13.
pubmed: 26670707 doi: 10.1017/S0033291715002500
Guan J, Cai JJ, Ji G, Sham PC. Commonality in dysregulated expression of gene sets in cortical brains of individuals with autism, schizophrenia, and bipolar disorder. Transl Psychiatry. 2019;9:1–15.
doi: 10.1038/s41398-019-0488-4
Lee SH, Ripke S, Neale BM, Faraone SV, Purcell SM, Perlis RH, et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet. 2013;45:984–94.
pubmed: 23933821 doi: 10.1038/ng.2711
Bulik-Sullivan B, Finucane HK, Anttila V, ReproGen Consortium, Psychiatric Genomics Consortium, Genetic Consortium for Anorexia Nervosa of the Wellcome Trust Case Control Consortium 3. et al. An atlas of genetic correlations across human diseases and traits. Nat Genet. 2015;47:1236–41.
pubmed: 26414676 pmcid: 4797329 doi: 10.1038/ng.3406
NV Radonjić, JL Hess, P Rovira, O Andreassen, JK Buitelaar, CRK Ching, et al. Structural Brain Imaging Studies Offer Clues about the Effects of the Shared Genetic Etiology among Neuropsychiatric Disorders. bioRxiv809582; https://doi.org/10.1101/809582
Disorder WC for the A-D, Disorder AS, Disorder B, Disorder MD, Disorder O-C, Groups and SEW. et al. Virtual Histology of Cortical Thickness and Shared Neurobiology in 6 Psychiatric Disorders. JAMA Psychiatry. 2020;26:2020 https://doi.org/10.1001/jamapsychiatry.2020.2694 . August.
doi: 10.1001/jamapsychiatry.2020.2694
Rosell DR, Futterman SE, McMaster A, Siever LJ. Schizotypal personality disorder: a current review. Curr Psychiatry Rep. 2014;16:452.
pubmed: 24828284 pmcid: 4182925 doi: 10.1007/s11920-014-0452-1
Siever LJ, Davis KL. The pathophysiology of schizophrenia disorders: perspectives from the spectrum. Am J Psychiatry. 2004;161:398–413.
pubmed: 14992962 doi: 10.1176/appi.ajp.161.3.398
de Zwarte SMC, Brouwer RM, Agartz I, Alda M, Aleman A, Alpert KI, et al. The Association Between Familial Risk and Brain Abnormalities Is Disease Specific: An ENIGMA-Relatives Study of Schizophrenia and Bipolar Disorder. Biol Psychiatry. 2019;86:545–56.
pubmed: 31443932 pmcid: 7068800 doi: 10.1016/j.biopsych.2019.03.985
Tamnes CK, Herting MM, Goddings A-L, Meuwese R, Blakemore S-J, Dahl RE, et al. Development of the Cerebral Cortex across Adolescence: A Multisample Study of Inter-Related Longitudinal Changes in Cortical Volume, Surface Area, and Thickness. J Neurosci Off J Soc Neurosci. 2017;37:3402–12.
doi: 10.1523/JNEUROSCI.3302-16.2017
Gogtay N, Giedd JN, Lusk L, Hayashi KM, Greenstein D, Vaituzis AC, et al. Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci. 2004;101:8174–9.
pubmed: 15148381 pmcid: 419576 doi: 10.1073/pnas.0402680101
Sowell ER, Thompson PM, Leonard CM, Welcome SE, Kan E, Toga AW. Longitudinal Mapping of Cortical Thickness and Brain Growth in Normal Children. J Neurosci. 2004;24:8223–31.
pubmed: 15385605 pmcid: 6729679 doi: 10.1523/JNEUROSCI.1798-04.2004
Rakic P. Specification of cerebral cortical areas. Science. 1988;241:170–6.
pubmed: 3291116 doi: 10.1126/science.3291116
Romero-Garcia R, Seidlitz J, Whitaker KJ, Morgan SE, Fonagy P, Dolan RJ, et al. Schizotypy-Related Magnetization of Cortex in Healthy Adolescence Is Colocated With Expression of Schizophrenia-Related Genes. Biol Psychiatry. 2019;13:2019 https://doi.org/10.1016/j.biopsych.2019.12.005 . December.
doi: 10.1016/j.biopsych.2019.12.005
Whitaker KJ, Vértes PE, Romero-Garcia R, Váša F, Moutoussis M, Prabhu G, et al. Adolescence is associated with genomically patterned consolidation of the hubs of the human brain connectome. Proc Natl Acad Sci. 2016;113:9105–10.
pubmed: 27457931 pmcid: 4987797 doi: 10.1073/pnas.1601745113
Smieskova R, Fusar-Poli P, Allen P, Bendfeldt K, Stieglitz RD, Drewe J, et al. Neuroimaging predictors of transition to psychosis–a systematic review and meta-analysis. Neurosci Biobehav Rev. 2010;34:1207–22.
pubmed: 20144653 doi: 10.1016/j.neubiorev.2010.01.016
ENIGMA Clinical High Risk for Psychosis Working Group, Jalbrzikowski M, Hayes RA, Wood SJ, Nordholm D, Zhou JH, et al. Association of Structural Magnetic Resonance Imaging Measures With Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis: An ENIGMA Working Group Mega-analysis. JAMA Psychiatry. 2021;5:2021 https://doi.org/10.1001/jamapsychiatry.2021.0638 . May.
doi: 10.1001/jamapsychiatry.2021.0638
Neilson E, Shen X, Cox SR, Clarke T-K, Wigmore EM, Gibson J, et al. Impact of Polygenic Risk for Schizophrenia on Cortical Structure in UK Biobank. Biol Psychiatry. 2019;22:2019 https://doi.org/10.1016/j.biopsych.2019.04.013 . April.
doi: 10.1016/j.biopsych.2019.04.013
Ward J, Lyall LM, Bethlehem RAI, Ferguson A, Strawbridge RJ, Lyall DM, et al. Novel genome-wide associations for anhedonia, genetic correlation with psychiatric disorders, and polygenic association with brain structure. Transl Psychiatry. 2019;9:1–9.
doi: 10.1038/s41398-019-0635-y
Evermann U, Gaser C, Besteher B, Langbein K, Nenadić I. Cortical Gyrification, Psychotic-Like Experiences, and Cognitive Performance in Nonclinical Subjects. Schizophr Bull. https://doi.org/10.1093/schbul/sbaa068 .

Auteurs

Matthias Kirschner (M)

McConnell Brain Imaging Centre, Montréal Neurological Institute, McGill University, Montréal, QC, Canada.
Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich, Zurich, Switzerland.

Benazir Hodzic-Santor (B)

McConnell Brain Imaging Centre, Montréal Neurological Institute, McGill University, Montréal, QC, Canada.

Mathilde Antoniades (M)

Department of Psychosis Studies, King's College London, London, UK.

Igor Nenadic (I)

University of Marburg, Marburg, Germany.

Tilo Kircher (T)

University of Marburg, Marburg, Germany.

Axel Krug (A)

University of Marburg, Marburg, Germany.
Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Germany.

Tina Meller (T)

University of Marburg, Marburg, Germany.

Dominik Grotegerd (D)

Department of Psychiatry, University of Münster, Münster, Germany.

Alex Fornito (A)

Turner Institute for Brain and Mental Health, School of Psychological Sciences and Monash Biomedical Imaging, Monash University, Melbourne, VIC, Australia.

Aurina Arnatkeviciute (A)

Turner Institute for Brain and Mental Health, School of Psychological Sciences and Monash Biomedical Imaging, Monash University, Melbourne, VIC, Australia.

Mark A Bellgrove (MA)

Turner Institute for Brain and Mental Health, School of Psychological Sciences and Monash Biomedical Imaging, Monash University, Melbourne, VIC, Australia.

Jeggan Tiego (J)

Turner Institute for Brain and Mental Health, School of Psychological Sciences and Monash Biomedical Imaging, Monash University, Melbourne, VIC, Australia.

Udo Dannlowski (U)

Department of Psychiatry, University of Münster, Münster, Germany.

Katharina Koch (K)

Department of Psychiatry, University of Münster, Münster, Germany.

Carina Hülsmann (C)

Department of Psychiatry, University of Münster, Münster, Germany.

Harald Kugel (H)

University Clinic for Radiology, University of Münster, Münster, Germany.

Verena Enneking (V)

Department of Psychiatry, University of Münster, Münster, Germany.

Melissa Klug (M)

Department of Psychiatry, University of Münster, Münster, Germany.

Elisabeth J Leehr (EJ)

Department of Psychiatry, University of Münster, Münster, Germany.

Joscha Böhnlein (J)

Department of Psychiatry, University of Münster, Münster, Germany.

Marius Gruber (M)

Department of Psychiatry, University of Münster, Münster, Germany.

David Mehler (D)

Department of Psychiatry, University of Münster, Münster, Germany.

Pamela DeRosse (P)

Division of Psychiatry Research, Zucker Hillside Hospital, Northwell Health, Glen Oaks, NY, USA.
The Feinstein Institutes for Medical Research, Center for Psychiatric Neuroscience, Manhasset, NY, USA.
Department of Psychiatry, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.

Ashley Moyett (A)

Division of Psychiatry Research, Zucker Hillside Hospital, Northwell Health, Glen Oaks, NY, USA.

Bernhard T Baune (BT)

Department of Psychiatry, University of Münster, Münster, Germany.
Department of Psychiatry, Melbourne Medical School, University of Melbourne, Melbourne, VIC, Australia.

Melissa Green (M)

School of Psychiatry, University of New South Wales (UNSW), Sydney, NSW, Australia.
Neuroscience Research Australia (NeuRA), Randwick, NSW, Australia.

Yann Quidé (Y)

School of Psychiatry, University of New South Wales (UNSW), Sydney, NSW, Australia.
Neuroscience Research Australia (NeuRA), Randwick, NSW, Australia.

Christos Pantelis (C)

Melbourne Neuropsychiatry Centre, University of Melbourne, Melbourne, VIC, Australia.

Raymond Chan (R)

Institute of Psychology, Chinese Academy of Sciences, Beijing, China.

Yi Wang (Y)

Institute of Psychology, Chinese Academy of Sciences, Beijing, China.

Ulrich Ettinger (U)

University of Bonn, Bonn, Germany.

Martin Debbané (M)

University of Geneva, Geneva, Switzerland.

Melodie Derome (M)

University of Geneva, Geneva, Switzerland.

Christian Gaser (C)

Jena University Hospital, Jena, Germany.

Bianca Besteher (B)

Jena University Hospital, Jena, Germany.

Kelly Diederen (K)

Department of Psychosis Studies, King's College London, London, UK.

Tom J Spencer (TJ)

Department of Psychosis Studies, King's College London, London, UK.

Paul Fletcher (P)

Department of Psychiatry, University of Cambridge, Cambridge, UK.

Wulf Rössler (W)

Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Department of Psychiatry and Psychotherapy, Charité University Medicine, Berlin, Germany.
Institute of Psychiatry, School of Medicine, University of São Paulo, São Paulo, Brazil.

Lukasz Smigielski (L)

Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Veena Kumari (V)

Brunel University London, Uxbridge, UK.

Preethi Premkumar (P)

Brunel University London, Uxbridge, UK.

Haeme R P Park (HRP)

School of Psychology, University of Auckland, Auckland, New Zealand.

Kristina Wiebels (K)

School of Psychology, University of Auckland, Auckland, New Zealand.

Imke Lemmers-Jansen (I)

Free University, Amsterdam, the Netherlands.

James Gilleen (J)

Department of Psychosis Studies, King's College London, London, UK.
University of Roehampton, London, UK.

Paul Allen (P)

University of Roehampton, London, UK.

Petya Kozhuharova (P)

University of Roehampton, London, UK.

Jan-Bernard Marsman (JB)

Department of Biomedical Sciences of Cells and Systems, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

Irina Lebedeva (I)

Mental Health Research Center, Moscow, Russian Federation.

Alexander Tomyshev (A)

Mental Health Research Center, Moscow, Russian Federation.

Anna Mukhorina (A)

Mental Health Research Center, Moscow, Russian Federation.

Stefan Kaiser (S)

Department of Psychiatry, Geneva University Hospital, Geneva, Switzerland.

Anne-Kathrin Fett (AK)

Department of Psychosis Studies, King's College London, London, UK.
City, University London, London, UK.

Iris Sommer (I)

Department of Biomedical Sciences of Cells and Systems, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

Sanne Schuite-Koops (S)

Department of Biomedical Sciences of Cells and Systems, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

Casey Paquola (C)

McConnell Brain Imaging Centre, Montréal Neurological Institute, McGill University, Montréal, QC, Canada.

Sara Larivière (S)

McConnell Brain Imaging Centre, Montréal Neurological Institute, McGill University, Montréal, QC, Canada.

Boris Bernhardt (B)

McConnell Brain Imaging Centre, Montréal Neurological Institute, McGill University, Montréal, QC, Canada.

Alain Dagher (A)

McConnell Brain Imaging Centre, Montréal Neurological Institute, McGill University, Montréal, QC, Canada.

Phillip Grant (P)

Fresenius University of Applied Sciences, Frankfurt am Main, Germany.

Theo G M van Erp (TGM)

Clinical Translational Neuroscience Laboratory, Department of Psychiatry and Human Behavior, University of California Irvine, Irvine, CA, USA.
Center for the Neurobiology of Learning and Memory, University of California Irvine, Irvine, CA, USA.

Jessica A Turner (JA)

Imaging Genetics and Neuroinformatics Lab, Georgia State University, Atlanta, GA, USA.

Paul M Thompson (PM)

Imaging Genetics Center, Mark and Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine of the University of Southern California, Marina del Rey, CA, USA.

André Aleman (A)

Department of Biomedical Sciences of Cells and Systems, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

Gemma Modinos (G)

Department of Psychosis Studies, King's College London, London, UK. gemma.modinos@kcl.ac.uk.
MRC Centre for Neurodevelopmental Disorders, King's College London, London, UK. gemma.modinos@kcl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH